|
End-of-day quote
Shenzhen S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 3.780 CNY | -0.53% |
|
-2.58% | -14.67% |
| 08-26 | Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-22 | Fuan Pharmaceutical Subsidiary Gets China Approval for Three Injectable Drugs | MT |
| Market Cap | 4.5B 671M 585M 553M 502M 940M 64.39B 944M 6.62B 2.55B 32.74B 2.52B 2.46B 105B | P/E 2024 |
18.6x | P/E 2025 | 73.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.26B 636M 554M 523M 475M 891M 61.01B 894M 6.27B 2.42B 31.02B 2.39B 2.34B 99.8B | EV / Sales 2024 |
2.15x | EV / Sales 2025 | 2.9x |
| Free-Float |
68.44% | Yield 2024 |
1.12% | Yield 2025 | 1.58% |
| 1 day | -0.53% | ||
| 1 week | -2.58% | ||
| Current month | -4.55% | ||
| 1 month | -6.67% | ||
| 3 months | +7.08% | ||
| 6 months | -11.27% | ||
| Current year | -14.67% |
| 1 week | 3.71 |  | 3.87 |
| 1 month | 3.71 | | 4.2 |
| Current year | 3.24 | | 4.75 |
| 1 year | 3.24 | | 5 |
| 3 years | 2.92 | | 5.68 |
| 5 years | 2.92 | | 5.68 |
| 10 years | 2.87 | | 11.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lu Wang
CEO | Chief Executive Officer | 42 | 04/12/2023 |
Xue Song Yu
DFI | Director of Finance/CFO | 57 | 19/09/2009 |
Qin Tang
SEC | Corporate Secretary | 57 | 19/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhi Dong
BRD | Director/Board Member | 66 | 20/11/2024 |
Tian Xiang Wang
CHM | Chairman | 70 | 19/09/2009 |
Lu Wang
BRD | Director/Board Member | 42 | 10/12/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/7/20 A | Sell | Director | 3,000,000 | 0.3361% | ||
| 1/2/20 A | Sell | Executive/Senior Manager | 30,300 | 0.0034% | ||
| 1/2/20 A | Sell | Chief Financial Officer | 42,200 | 0.0047% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -2.58% | -18.18% | -11.68% | 674M | |
| -1.61% | -1.27% | +13.40% | +59.79% | 46.78B | |
| -1.02% | -3.01% | +36.66% | +100.50% | 37.88B | |
| +2.19% | +3.78% | +12.21% | +79.75% | 11.82B | |
| +1.32% | +1.54% | -10.59% | +12.87% | 11.61B | |
| -0.95% | -0.38% | +17.65% | +146.45% | 9.12B | |
| +0.39% | +2.72% | +29.99% | +39.46% | 7.38B | |
| +1.30% | +1.34% | +19.83% | +185.74% | 7.12B | |
| -0.06% | +1.94% | +39.71% | -18.67% | 7.21B | |
| +0.70% | -2.06% | -42.22% | +7.42% | 4.99B | |
| Average | +0.17% | +0.20% | +9.85% | +60.16% | 14.46B | |
| Weighted average by Cap. | -0.46% | -0.10% | +18.15% | +72.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.39B 357M 311M 294M 267M 500M 34.24B 502M 3.52B 1.36B 17.41B 1.34B 1.31B 56.01B | 1.74B 259M 226M 214M 194M 363M 24.89B 365M 2.56B 987M 12.65B 974M 953M 40.71B |
| Net income | 280M 41.76M 36.41M 34.38M 31.22M 58.49M 4.01B 58.74M 412M 159M 2.04B 157M 153M 6.55B | 77M 11.49M 10.02M 9.46M 8.59M 16.09M 1.1B 16.16M 113M 43.73M 560M 43.16M 42.2M 1.8B |
| Net Debt | -171M -25.45M -22.19M -20.95M -19.03M -35.65M -2.44B -35.8M -251M -96.85M -1.24B -95.59M -93.47M -3.99B | -236M -35.25M -30.74M -29.02M -26.36M -49.38M -3.38B -49.59M -348M -134M -1.72B -132M -129M -5.53B |
Employees
2,988
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | CN¥3.780 | -0.53% | 12,034,770 |
| 17/09/26 | CN¥3.800 | +0.80% | 8,010,425 |
| 16/09/26 | CN¥3.770 | +0.53% | 8,141,453 |
| 15/09/26 | CN¥3.750 | -2.85% | 12,394,800 |
| 14/09/26 | CN¥3.860 | +1.31% | 9,107,100 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300194 Stock
Select your edition
All financial news and data tailored to specific country editions
